Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Full description
titration of drugs
run-in period: eligible subjects are screened and baseline blood samples are obtained
study period: 12 weeks
blood sampling and measurement of serum biomarkers
assays of human EPCs
measurement of flow-mediated dilatation (FMD) of left brachial artery by sonography
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: high-risk patients who have at least one of the following situations without pre-existing cardiovascular disease including peripheral artery disease or coronary artery disease:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
71 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal